KRON
Price
$0.95
Change
-$0.01 (-1.04%)
Updated
Dec 18, 04:18 PM (EDT)
91 days until earnings call
VERA
Price
$41.43
Change
-$2.48 (-5.65%)
Updated
Dec 18, 04:59 PM (EDT)
92 days until earnings call
Ad is loading...

KRON vs VERA

Header iconKRON vs VERA Comparison
Open Charts KRON vs VERABanner chart's image
Kronos Bio
Price$0.95
Change-$0.01 (-1.04%)
Volume$600
CapitalizationN/A
Vera Therapeutics
Price$41.43
Change-$2.48 (-5.65%)
Volume$16.42K
CapitalizationN/A
KRON vs VERA Comparison Chart
Loading...
KRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KRON vs. VERA commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KRON is a Hold and VERA is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (KRON: $0.96 vs. VERA: $43.91)
Brand notoriety: KRON and VERA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KRON: 139% vs. VERA: 71%
Market capitalization -- KRON: $57.93M vs. VERA: $2.78B
KRON [@Biotechnology] is valued at $57.93M. VERA’s [@Biotechnology] market capitalization is $2.78B. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KRON’s FA Score shows that 1 FA rating(s) are green whileVERA’s FA Score has 0 green FA rating(s).

  • KRON’s FA Score: 1 green, 4 red.
  • VERA’s FA Score: 0 green, 5 red.
According to our system of comparison, both KRON and VERA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KRON’s TA Score shows that 6 TA indicator(s) are bullish while VERA’s TA Score has 3 bullish TA indicator(s).

  • KRON’s TA Score: 6 bullish, 4 bearish.
  • VERA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, KRON is a better buy in the short-term than VERA.

Price Growth

KRON (@Biotechnology) experienced а -8.92% price change this week, while VERA (@Biotechnology) price change was -6.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Reported Earning Dates

KRON is expected to report earnings on Mar 19, 2025.

VERA is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERA($2.78B) has a higher market cap than KRON($57.9M). VERA YTD gains are higher at: 185.501 vs. KRON (-23.496). KRON has higher annual earnings (EBITDA): -80.84M vs. VERA (-127.57M). VERA has more cash in the bank: 353M vs. KRON (125M). KRON has less debt than VERA: KRON (25.8M) vs VERA (54.9M). KRON has higher revenues than VERA: KRON (9.86M) vs VERA (0).
KRONVERAKRON / VERA
Capitalization57.9M2.78B2%
EBITDA-80.84M-127.57M63%
Gain YTD-23.496185.501-13%
P/E RatioN/AN/A-
Revenue9.86M0-
Total Cash125M353M35%
Total Debt25.8M54.9M47%
TECHNICAL ANALYSIS
Technical Analysis
KRONVERA
RSI
ODDS (%)
Bullish Trend 7 days ago
86%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 14 days ago
78%
Bullish Trend 20 days ago
88%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Ad is loading...
KRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TORO2.95N/A
N/A
Toro Corp
ARI9.06-0.06
-0.66%
Apollo Commercial Real Estate Finance
WM209.00-2.64
-1.25%
Waste Management
MTH163.80-2.53
-1.52%
Meritage Homes Corp
CVRX13.16-0.22
-1.64%
CVRx

KRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, KRON has been loosely correlated with CYTK. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if KRON jumps, then CYTK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRON
1D Price
Change %
KRON100%
-0.39%
CYTK - KRON
42%
Loosely correlated
-2.53%
VERA - KRON
38%
Loosely correlated
-0.11%
AXON - KRON
38%
Loosely correlated
-2.09%
ARRY - KRON
37%
Loosely correlated
+6.01%
BTAI - KRON
36%
Loosely correlated
-4.01%
More